Sitagliptin Hydrochloride News

Sitagliptin Hydrochloride currently has 12 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Sitagliptin Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: For adult patients with type 2 diabetes mellitus, Sitagliptin Accord is indicated to improve glycaemic control: as monotherapy:- in patients inadequately controlled by diet and exercise alone and for...
Evidence level: L5
Predicted indications (20):
- opsismodysplasia (98.9%)
- diabetes mellitus (disease) (98.7%)
- classic stiff person syndrome (98.7%)
- focal stiff limb syndrome (98.7%)
- thiamine-responsive dysfunction syndrome (98.6%)
- drug-induced localized lipodystrophy (98.0%)
- pancreatic agenesis (97.9%)
- centrifugal lipodystrophy (97.9%)
- pressure-induced localized lipoatrophy (97.8%)
- idiopathic localized lipodystrophy (97.7%)
- autoimmune oophoritis (88.0%)
- type 1 diabetes mellitus (86.5%)
- cholangiocarcinoma, susceptibility to (65.0%)
- hemoglobin C-beta-thalassemia syndrome (62.0%)
- homozygous familial hypercholesterolemia (60.5%)
- mitral valve prolapse, myxomatous (60.4%)
- pancreas, dorsal, agenesis of (58.4%)
- familial chronic myelocytic leukemia-like syndrome (58.2%)
- woolly hair, autosomal recessive 3 (58.1%)
- hypercarotenemia and vitamin A deficiency, autosomal recessive (58.0%)